USFDA classifies Jubilant Pharmova Nanjangud facility as Voluntary Action Indicated Ruchika Sharma9 March 2023 2:15 PM ISTNoida: Jubilant Pharmova Limited has announced that pursuant to the United States Food and Drug Administration (USFDA) inspection of its API...
Jubilant Draximage bags USFDA nod for Technetium Mertiatide Injection Ruchika Sharma1 Feb 2023 12:15 PM ISTNoida: Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Draximage Inc has announced that it has received approval from the US Food...
Jubilant Pharmova gets 8 USFDA obervations for Nanjangud facility Ruchika Sharma15 Dec 2022 3:00 PM ISTNoida: Jubilant Pharmova Limited has recently announced that the United States Food and Drug Administration (USFDA) has issued eight observations...
Jubilant Generics Roorkee facility determined as official action indicated Ruchika Sharma31 Oct 2022 12:46 PM ISTNoida: Jubilant Pharmova Limited's wholly owned subsidiary Jubilant Pharma Limited, today announced that its subsidiary Jubilant Generics Limited...
Jubilant Pharmova Roorkee facility gets 6 USFDA observations Rahul Verma5 Aug 2022 4:12 PM ISTJubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid Dosage...
USFDA issues 6 observations for Jubilant Pharmova Roorkee facility Ruchika Sharma3 Aug 2022 12:15 PM ISTNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid...
USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from list of excepted products from import Ruchika Sharma14 July 2022 4:09 PM ISTPost this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Jubilant to double US injectable capacity at cost of Rs 1498 crore Ruchika Sharma31 May 2022 11:46 AM ISTThis agreement is in addition to the $92 million filling line expansion announced in November 2021, which will be commercially available by the end of...
Jubilant Pharmova net profit declines 3 percent to Rs 143 crore in Q2 Ruchika Sharma25 Oct 2021 1:01 PM ISTNew Delhi: Pharmaceuticals firm Jubilant Pharmova Ltd on Friday reported a 3 per cent decline in consolidated net profit from continuing operations at...
Jubilant Pharma to remain integral to group post reorganisation: SnP Ruchika Sharma18 Aug 2021 1:01 PM ISTSingapore: S&P Global Ratings said on Tuesday that Jubilant Pharma Ltd will remain integral to the broader group even after its proposed...
Jubilant Pharmova reports Rs 160 crore net profit in Q1 Ruchika Sharma25 July 2021 9:15 AM ISTNew Delhi: Drug firm Jubilant Pharmova on Friday reported a consolidated net profit of Rs 160.49 crore from continuing operations for the quarter...
Jubilant Pharmova Roorkee facility placed under USFDA import alert Ruchika Sharma16 July 2021 10:30 AM ISTThe products that get impacted due to the import alert contributed to less than 3% of FY21 total revenues for the Company.
